Explore more publications!

Press Releases

DEADLINE ALERT for VRNS, ARDT, CRWV, BBWI: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
Good Dad Act Committee Celebrates Historic Achievements and Champions Nationwide Family Law Reform
KLAR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Klarna Group plc
SCDE Seeks Partners for 2026 Summer Meals Programs

SCDE Seeks Partners for 2026 Summer Meals Programs

Extraordinary Estate Near Houston, Texas to Sell via Concierge Auctions
Semi-Automatic Stretch Wrappers Market
ONEflight International named Official Private Aviation Partner of the McLaren Mastercard Formula 1 Team 
AIM ImmunoTech Announces Key Dates and Terms Related to Announced Rights Offering
Crypto Protocol Mutuum Finance (MUTM) Finalized Halborn Security Review as Roadmap Phase 2 Advances
Mutuum Finance (MUTM) Announces New V1 Protocol Launch Updates as Funding Nears $20M
Community Regional Charter School Spreads Holiday Cheer Through First-Ever ‘Giving Room’

Community Regional Charter School Spreads Holiday Cheer Through First-Ever ‘Giving Room’

Berger Montague PC Investigating Claims on Behalf of BellRing Brands, Inc. (NYSE: BRBR) Investors After Class Action Filing
- Utah's Employment Summary: December 2025

- Utah's Employment Summary: December 2025

Laurel Health Centers Data Breach Claims Investigated by Lynch Carpenter
Freeze Out for the Fisher House Event Set for February 6–7 at West Acres Mall

Freeze Out for the Fisher House Event Set for February 6–7 at West Acres Mall

Varonis Systems, Inc. (VRNS) Hit with Securities Class Action Amid Renewal and ARR Concerns That Drove Shares Down 48% - Hagens Berman
Sanjay Puri in Conversation with Dr. James H. Dickerson on AI Standards and Innovation— RegulatingAI Podcast
NEQSOL Holding Explores Investment Opportunities in the Kingdom of Bahrain
 WithIt Announces the 2026  WOW Awards Recipients with News about their Sold Out Event
Lipid Nanoparticle Manufacturing Market: An 18.9% CAGR Market Driven by Nucleic Acid Therapies

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions